Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

HEXO Corp

Tilray Brands

Hint: The reason starts with the letter "D."

Why Marijuana Stocks Tilray, HEXO, and Cronos Group Were on Fire Thursday

Aurora Cannabis

Aphria

Canopy Growth

Innovative Industrial Properties

Trulieve Cannabis Corp.

The long-struggling sector had solid gains Thursday.

Stock Markets Rise as Marijuana Stocks Show New Signs of Life

Cronos lacks any positive catalysts ahead, other than holding Altria’s billions of cash in investments The post Why Cronos Has Too Many Red Flags That Should Scare Investors Away appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG America’s #1 Stock Picker Reveals His Next 1,000% Winner Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company Could Tiny “Super” Battery Kill Big Tech?

Why Cronos Has Too Many Red Flags That Should Scare Investors Away

GrowGeneration Corp

GW Pharmaceuticals

Village Farms International

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and best performance for October.

Top Marijuana Stocks on the NASDAQ for October 2020

Curaleaf Holdings, Inc.

Investors looking for marijuana stocks to buy need to be careful, as a shakeout is coming. But, these 7 names will see the other side.

7 Marijuana Stocks to Buy That Will Survive 2020

Its partnership with tobacco giant Altria is appealing, but keep an eye on these three issues before you pick this pot stock.

Don't Buy Cronos Group Stock Until You See This

TORONTO, Sept.  15, 2020  (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that on September 15, 2020, the Company was recognized by the Toronto Stock Exchange as the third top-performing company on the Toronto Stock Exchange’s 2020 TSX30 list, a flagship program recognizing the 30 top-performing TSX stocks over a three-year period based on dividend-adjusted share price appreciation.

Cronos Group Recognized by the Toronto Stock Exchange’s TSX30 Program

TORONTO, Sept.  14, 2020  (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the CIBC 19th Annual Eastern Institutional Investor Conference on Thursday, September 17, 2020 at 2:40 p.m. EDT.

Cronos Group Inc. to Present at the CIBC 19th Annual Eastern Institutional Investor Conference

Altria

Over a five-year stretch, these cannabis stocks offer a compound annual growth rate ranging between 59% and 105%.

The 3 Fastest-Growing Pot Stocks Through 2024

OrganiGram Holdings Inc.

Investors will want to preserve their hard-earned capital by staying away from these marijuana companies for now.

3 Cannabis Stocks to Avoid Like the Plague in September

The marijuana industry's leadership carousel keeps on turning.

Cronos Group Names a New CEO

An uninspiring earnings report sent shares backsliding in August.

Why Cronos Group Declined 17.7% in August

Oddly enough, these are the two most cash-rich pot stocks in North America.

The Only 2 Cannabis Stocks Billionaires Sold in Q2

These seven marijuana stocks to buy are solid long-term investments, because the industry still has a lot of growth left.

7 Marijuana Stocks to Buy As the Industry Continues to Grow

The cannabis company's profits took a turn for the worse in the recent quarter.

3 Scary Numbers From Cronos' Second-Quarter Results

Both of these Canadian pot stocks are losers so far in 2020, but one seems better positioned to return to the winners' column.

Better Cannabis Stock: Cronos Group vs. Tilray

Beaten and bruised, CRON stock has a chance to reverse course sharply over the next few months as its biggest headwinds turn into tailwinds. 
The post The Case for Cronos Stock to Rise By 100% appeared first on InvestorPlace.

The Case for Cronos Stock to Rise By 100%

Marijuana stocks could rally in a big way if Democrats seize control of the House, Senate and White House in November.
The post 5 Marijuana Stocks to Buy For A “Blue Wave” Election appeared first on InvestorPlace.

5 Marijuana Stocks to Buy For A “Blue Wave” Election

New Age Beverages

Constellation Brands

Many aspects of the marijuana industry are now encountering growing pains.

3 Red-Hot Cannabis Trends That Have Fizzled Out

Beyond The Numbers: The Case For Cronos

Margin compression could become commonplace among Canadian pot stocks because of this.

Canada's Marijuana Industry Has a New Problem

Here are the two best marijuana stocks to choose from in a sector that's on the edge of a massive turnaround.

2 Top Marijuana Stocks to Watch in August

The cannabis company is facing a host of challenges.

Why Cronos Group Stock Plunged Today

There were a few bright spots for Cronos in Q2. But not enough of them.

What's Behind Cronos Group's Disappointing Q2 Results

Cronos Group Inc. (CRON) CEO Mike Gorenstein on Q2 2020 Results - Earnings Call Transcript

News for Cronos Group Stock (CRON)